Hypoxia, mitochondria and cancer

被引：0
|
作者：
Mazure, Nathalie [1 ,2 ,3 ]
Clavel, Stephan [4 ]
机构：
[1] Univ Nice Sophia Antipolis, CNRS UMR7284, Inst Rech Canc & Vieillissement Nice IRCAN, Inserm U1081, Nice, France
[2] Ctr Antoine Lacassagne, Nice, France
[3] CNRS, MicroNit, Grp Rech 3697, Nice, France
[4] Univ Nice Sophia Antipolis, Ctr Mediterraneen Med Mol, Equipe Physiopathol Cellulaire & Mol Obes & Diabe, Inserm U1065,C3M, Nice, France
来源：
CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION | 2016年 / 20卷 / 10期
关键词：
Cancer; HIF; Hypoxia; Mitochondria;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Hypoxia plays a predominant role in tumor development and is a sign of poor prognosis for the patient. HIF (Hypoxia-Inducible Factor) is the transcription factor of the cellular response to hypoxia. Mitochondrion is an essential actor in resistance to apoptosis in cancer cells. Mitochondrion participates actively in the metabolic reprogramming of tumor cells. Its physiology probably plays an important role in many cancer processes, A better understanding of these mechanisms is an important future issue in oncology.
引用
收藏
页码：294 / 298
页数：5
相关论文
共 50 条
  • [1] Mitochondria in brain hypoxia
    Lenart, Jacek
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2017, 71 : 118 - 128
  • [2] Distinctions and similarities of cell bioenergetics and the role of mitochondria in hypoxia, cancer, and embryonic development
    Jezek, Petr
    Plecita-Hlavata, Lydie
    Smolkova, Katarina
    Rossignol, Rodrigue
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2010, 42 (05) : 604 - 622
  • [3] Targeting Mitochondria for Cancer Treatment
    Zorova, Ljubava D.
    Abramicheva, Polina A.
    Andrianova, Nadezda V.
    Babenko, Valentina A.
    Zorov, Savva D.
    Pevzner, Irina B.
    Popkov, Vasily A.
    Semenovich, Dmitry S.
    Yakupova, Elmira I.
    Silachev, Denis N.
    Plotnikov, Egor Y.
    Sukhikh, Gennady T.
    Zorov, Dmitry B.
    PHARMACEUTICS, 2024, 16 (04)
  • [4] Editorial: Hypoxia and angiogenesis in cancer
    Malekan, Mohammad
    Denko, Nicholas
    Mortara, Lorenzo
    Rathinavelu, Appu
    Parvizi, Mohammad Mahdi
    Natarajan, Umamaheswari
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [5] Mitochondria control acute and chronic responses to hypoxia
    McElroy, G. S.
    Chandel, N. S.
    EXPERIMENTAL CELL RESEARCH, 2017, 356 (02) : 217 - 222
  • [6] Metabolic adaptation to chronic hypoxia in cardiac mitochondria
    Lisa C. Heather
    Mark A. Cole
    Jun-Jie Tan
    Lucy J. A. Ambrose
    Simon Pope
    Amira H. Abd-Jamil
    Emma E. Carter
    Michael S. Dodd
    Kar Kheng Yeoh
    Christopher J. Schofield
    Kieran Clarke
    Basic Research in Cardiology, 2012, 107
  • [7] Metabolic adaptation to chronic hypoxia in cardiac mitochondria
    Heather, Lisa C.
    Cole, Mark A.
    Tan, Jun-Jie
    Ambrose, Lucy J. A.
    Pope, Simon
    Abd-Jamil, Amira H.
    Carter, Emma E.
    Dodd, Michael S.
    Yeoh, Kar Kheng
    Schofield, Christopher J.
    Clarke, Kieran
    BASIC RESEARCH IN CARDIOLOGY, 2012, 107 (03)
  • [8] Mitochondria in cancer: Not just innocent bystanders
    Frezza, Christian
    Gottlieb, Eyal
    SEMINARS IN CANCER BIOLOGY, 2009, 19 (01) : 4 - 11
  • [9] Mitochondria and Hypoxia-induced Gene Expression Mediated by Hypoxia-inducible Factors
    Chavez, Angela
    Miranda, Luis F.
    Pichiule, Paola
    Chavez, Juan C.
    MITOCHONDRIA AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISORDERS, 2008, 1147 : 312 - 320
  • [10] Hypoxia: A key regulator of angiogenesis in cancer
    Liao, Debbie
    Johnson, Randall S.
    CANCER AND METASTASIS REVIEWS, 2007, 26 (02) : 281 - 290
12345